![Apotheke Zur Rose – Im Spannungsfeld zwischen Kunden, Mitbewerbern und Politik -- Videomitschnitt der #dcomzh | Carpathia Digital Business Blog Apotheke Zur Rose – Im Spannungsfeld zwischen Kunden, Mitbewerbern und Politik -- Videomitschnitt der #dcomzh | Carpathia Digital Business Blog](https://blog.carpathia.ch/wp-content/uploads/sites/3/2020/11/eHealth-Oekosystem-Zur-Rose.jpg)
Apotheke Zur Rose – Im Spannungsfeld zwischen Kunden, Mitbewerbern und Politik -- Videomitschnitt der #dcomzh | Carpathia Digital Business Blog
DataCareer - New job: Senior Data Scientist (80-100%) at Zur Rose Group AG, Frauenfeld/Eastern Switzerland. Skills: e.g. SQL, R, Python, statistics/ML, Tableau/QlikView, ideally in the healthcare industry. https://www.datacareer.ch/job/5269/senior-data ...
![Mega pharmacy “Zur Rose” takes over TeleClinic and fetches another 213 million CHF while APORA announces its start one month ago! | by Falk Altenhöfer | Medium Mega pharmacy “Zur Rose” takes over TeleClinic and fetches another 213 million CHF while APORA announces its start one month ago! | by Falk Altenhöfer | Medium](https://miro.medium.com/max/883/1*OsdCJ9aFtgptgdKxnurrEQ.jpeg)
Mega pharmacy “Zur Rose” takes over TeleClinic and fetches another 213 million CHF while APORA announces its start one month ago! | by Falk Altenhöfer | Medium
![Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes - City Milano News Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes - City Milano News](https://citymilano.com/wp-content/uploads/2021/10/121168-roche-and-the-zur-rose-group-announce-collaboration-to-offer-innovative-health-journeys-for-people-living-with-diabetes.png)
Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes - City Milano News
![Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity](https://valueandopportunity.files.wordpress.com/2019/03/csm_zurrosegroupfinal_01_70165d445d.jpg)
Zur Rose AG (ISIN: CH0042615283) – Loss making failed IPO or long term growth opportunity ? | value and opportunity
![The logo of Swiss-based mail-order pharmacy and medical supplier Zur Rose Group is seen at the company's headquarters in Frauenfeld, Switzerland May 9, 2017. REUTERS/Arnd Wiegmann Stock Photo - Alamy The logo of Swiss-based mail-order pharmacy and medical supplier Zur Rose Group is seen at the company's headquarters in Frauenfeld, Switzerland May 9, 2017. REUTERS/Arnd Wiegmann Stock Photo - Alamy](https://l450v.alamy.com/450v/2cmtct6/the-logo-of-swiss-based-mail-order-pharmacy-and-medical-supplier-zur-rose-group-is-seen-at-the-companys-headquarters-in-frauenfeld-switzerland-may-9-2017-reutersarnd-wiegmann-2cmtct6.jpg)